Company intelligence / Profile preview

Scorpius BioManufacturing

San Antonio, Texas, United Statesscorpiusbiologics.com ↗

Ownership: Private
Employees: ~82
Development stage: Commercial

Overview

Scorpius BioManufacturing operates as an integrated U.S.-based CDMO specializing in mammalian, microbial, and cell therapy biologics. The company provides cGMP manufacturing, analytical testing, process development services and supports pharmaceutical and biotech companies from early-stage development through commercial production. It does not have its own therapeutic pipeline but enables the advancement of client programs into clinical trials and commercialization.

Modalities: Mammalian cell therapiesMicrobial biologicsProtein therapeuticsVaccinesAdvanced therapies/cell therapy-based products
Industry: Contract Manufacturing Organization

Partnerships

Tivic Health Systems for GMP manufacturing validation of Entolimod™

Beyond the preview

Go deeper on Scorpius BioManufacturing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scorpius BioManufacturing.

Explore the full profile